Risk Factors for Central Serous Chorioretinopathy: Multivariate Approach in a Case-Control Study

References

• Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium: Idiopathic central serous choroidopathy. Am J Ophthalmology 1967;63:587–615.
   Web of Science ®Google Scholar
• Schatz H. Central serous chorioretinopathy and serous detachment of the retinal pigment epithelium. Int Ophthalmol Clin 1975;15:159–168.
   PubMedGoogle Scholar
• Nicholson B, Noble J, Forooghian F, Meyerle C. Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol 2013;58:103–126.
   PubMed Web of Science ®Google Scholar
• Liew G, Quin G, Gillies M, Fraser-Bell S. Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clin Experiment Ophthalmol 2013;41:201–214.
   PubMed Web of Science ®Google Scholar
• Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Ho A, Orlock D. Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 1994;112:1057–1062.
   PubMed Web of Science ®Google Scholar
• Caccavale A, Romanazzi F, Imparato M, Negri A, Morano A, Ferentini F. Central serous chorioretinopathy: a pathogenetic model. Clin Ophthalmol 2011;5:239–243.
   PubMedGoogle Scholar
• Pryds A, Sander B, Larsen M. Characterization of subretinal fluid leakage in central serous chorioretinopathy. Invest Ophthalmol Vis Sci 2010;51:5853–5857.
   PubMed Web of Science ®Google Scholar
• Haimovici R, Gragoudas ES, Duker JS, Sjaarda RN, Eliott D. Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids. Ophthalmology 1997;104:1653–1660.
   PubMed Web of Science ®Google Scholar
• Mateo-Montoya A, Mauget-Faÿse M. Helicobacter pylori as a risk factor for central serous chorioretinopathy: Literature review. World J Gastrointest Pathophysiol 2014;5:355–358.
   PubMedGoogle Scholar
• Yannuzzi LA. Type A behavior and central serous chorioretinopathy. Retina 2012;32:709.
   PubMed Web of Science ®Google Scholar
• Miki A, Kondo N, Yanagisawa S, Bessho H, Honda S, Negi A. Common variants in the complement factor H gene confer genetic susceptibility to central serous chorioretinopathy. Ophthalmology 2014;121:1067–1072.
   PubMed Web of Science ®Google Scholar
• de Jong EK, Breukink MB, Schellevis RL, Bakker B, Mohr JK, Fauser S, et al. Chronic central serous chorioretinopathy is associated with genetic variants implicated in age-related macular degeneration. Ophthalmology 2015;122:562–570.
   PubMed Web of Science ®Google Scholar
• Moschos MM, Gazouli M, Gatzioufas Z, Brouzas D, Nomikarios N, Sivaprasad S, et al. Prevalence of the complement factor H and GSTM1 genes polymorphisms in patients with central serous chorioretinopathy. Retina 2016;36:402–407.
   PubMed Web of Science ®Google Scholar
• Mansuetta CC, Mason JO 3rd, Swanner J, Feist RM, White MF Jr, Thomley ML, et al. An association between central serous chorioretinopathy and gastroesophageal reflux disease. Am J Ophthalmol 2004;137:1096–1100.
   Google Scholar
• Cotticelli L, Borrelli M, D’Alessio AC, Menzione M, Villani A, Piccolo G, et al. Central serous chorioretinopathy and Helicobacter pylori. Eur J Ophthalmol 2006;16:274–278.
   PubMed Web of Science ®Google Scholar
• Tsai DC, Chen SJ, Huang CC, Chou P, Chung CM, Chan WL, et al. Risk of central serous chorioretinopathy in adults prescribed oral corticosteroids: a population-based study in Taiwan. Retina 2014;34:1867–1874.
   PubMed Web of Science ®Google Scholar
• Chen SN, Chen YC, Lian I. Increased risk of coronary heart disease in male patients with central serous chorioretinopathy: results of a population-based cohort study. Br J Ophthalmol 2014;98:110–114.
   PubMed Web of Science ®Google Scholar
• Brodie FL, Charlson ES, Aleman TS, Salvo RT, Gewaily DY, Lau MK, et al. Obstructive sleep apnea and central serous chorioretinopathy. Retina 2015;35:238–243.
   PubMed Web of Science ®Google Scholar
• Haimovici R, Koh S, Gagnon DR, Lehrfeld T, Wellik S; Central Serous Chorioretinopathy Case-Control Study Group. Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology 2004;111:244–249.
   Google Scholar
• Tittl MK, Spaide RF, Wong D, Pilotto E, Yannuzzi LA, Fisher YL, et al. Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol 1999;128:63–68.
   PubMed Web of Science ®Google Scholar
• Eom Y, Oh J, Kim SW, Huh K. Systemic factors associated with central serous chorioretinopathy in Koreans. Korean J Ophthalmol 2012;26:260–264.
   PubMedGoogle Scholar
• Leveque TK, Yu L, Musch DC, Chervin RD, Zacks DN. Central serous chorioretinopathy and risk for obstructive sleep apnea. Sleep Breath 2007;11:253–257.
   PubMed Web of Science ®Google Scholar
• Kloos P, Laube I, Thoelen A. Obstructive sleep apnea in patients with central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 2008;246:1225–1228.
   PubMed Web of Science ®Google Scholar
• Karadimas P, Bouzas EA. Glucocorticoid use represents a risk factor for central serous chorioretinopathy: a prospective, case-control study. Graefes Arch Clin Exp Ophthalmol 2004;242:800–802.
   PubMed Web of Science ®Google Scholar
• Carvalho-Recchia CA, Yannuzzi LA, Negrão S, Spaide RF, Freund KB, Rodriguez-Coleman H, et al. Corticosteroids and central serous chorioretinopathy. Ophthalmology 2002;109:1834–1837.
   PubMed Web of Science ®Google Scholar
• Yannuzzi LA. Type A behavior and central serous chorioretinopathy. Trans Am Ophthalmol Soc 1986;84:799–845.
   PubMedGoogle Scholar
• Conrad R, Weber NF, Lehnert M, Holz FG, Liedtke R, Eter N. Alexithymia and emotional distress in patients with central serous chorioretinopathy. Psychosomatics 2007;48:489–495.
   PubMed Web of Science ®Google Scholar
• Sun J, Tan J, Wang Z, Yang H, Zhu X, Li L. Effect of catecholamine on central serous chorioretinopathy. J Huazhong Univ Sci Technolog Med Sci 2003;23:313–316.
   PubMedGoogle Scholar
• Bousquet E, Dhundass M, Lehmann M, Rothschild PR, Bayon V, Leger D, et al. Shift Work: A Risk Factor for Central Serous Chorioretinopathy. Am J Ophthalmol 2016;165:23–28.
   PubMed Web of Science ®Google Scholar
• Bernasconi P, Messmer E, Bernasconi A, Thölen A. Assessment of the sympatho-vagal interaction in central serous chorioretinopathy measured by power spectral analysis of heart rate variability. Graefes Arch Clin Exp Ophthalmol 1998;236:571–576.
   PubMed Web of Science ®Google Scholar
• Chen SN, Lian I, Chen YC, Ho JD. Increased incidence of peptic ulcer disease in central serous chorioretinopathy patients: a population-based retrospective cohort study. Retina 2015;35:231–237.
   PubMed Web of Science ®Google Scholar
• Giusti C. Association of Helicobacter pylori with central serous chorioretinopathy: hypotheses regarding pathogenesis. Med Hypotheses 2004;63:524–527.
   PubMed Web of Science ®Google Scholar
• Lamb DJ, El-Sankary W, Ferns GA. Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunisation. Atherosclerosis 2003;167:177–185.
   PubMed Web of Science ®Google Scholar
• Asensio-Sánchez VM, Rodríguez-Delgado B, García-Herrero E, Cabo-Vaquera V, García-Loygorri C. Central serous chorioretinopathy as an extradigestive manifestation of Helicobacter pylori gastric infection. Arch Soc Esp Oftalmol 2008;83:177–182.
   PubMedGoogle Scholar
• Casella AM, Berbel RF, Bressanim GL, Malaguido MR, Cardillo JA. Helicobacter pylori as a potential target for the treatment of central serous chorioretinopathy. Clinics 2012;67:1047–1052.
   PubMed Web of Science ®Google Scholar
• Dang Y, Mu Y, Zhao M, Li L, Guo Y, Zhu Y. The effect of eradicating Helicobacter pylori on idiopathic central serous chorioretinopathy patients. Ther Clin Risk Manag 2013;9:355–360.
   PubMed Web of Science ®Google Scholar
• Sun H, Mayhan WG. Superoxide dismutase ameliorates impaired nitric oxide synthase-dependent dilatation of the basilar artery during chronic alcohol consumption. Brain Res 2001;891:116–122.
   PubMed Web of Science ®Google Scholar
• Spaide RF, Hall L, Haas A, Campeas L, Yannuzzi LA, Fisher YL, et al. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 1996;16:203–213.
   PubMed Web of Science ®Google Scholar
• Kitzman DW, Herrington DM, Brubaker PH, Moore JB, Eggebeen J, Haykowsky MJ. Carotid arterial stiffness and its relationship to exercise intolerance in older patients with heart failure and preserved ejection fraction. Hypertension 2013;61:112–119.
   PubMed Web of Science ®Google Scholar
• Sogutlu Sari E, Yazici A, Eser B, Erol MK, Kilic A, Ermis SS, et al. The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in central serous chorioretinopathy and its association with plasma PAI-1 levels. Cutan Ocul Toxicol 2014;33:270–274.
   PubMed Web of Science ®Google Scholar
• Wang S, Wen F, Dai Z. The state of diopter and visual acuity in central serous chorioretinopathy. Yan Ke Xue Bao 2002;18:214–216.
   PubMedGoogle Scholar
• Manayath GJ, Arora S, Parikh H, Shah PK, Tiwari S, Narendran V. Is myopia a protective factor against central serous chorioretinopathy? Int J Ophthalmol 2016;9:266–270.
   PubMed Web of Science ®Google Scholar